KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angio... KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. 詳細を表示
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) today announced that the compensation committee of KalVista’s board of directors granted nine newly-hired employees inducement options to purchase an...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that Jeb Ledell has joined the Company as Chief Operating Officer (COO). Mr. Ledell is an accomplished public company COO with a...
–Continuing to build commercial infrastructure; on track for potential sebetralstat launch in Q2 2025– –Multinational regulatory submissions for sebetralstat position Company to transform...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista’s board of directors granted five newly-hired employees inducement options to purchase...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.095 | -12.2414756847 | 8.945 | 9.1549 | 7.85 | 173847 | 8.6573157 | CS |
4 | -0.678 | -7.95028142589 | 8.528 | 9.22 | 7.85 | 369033 | 8.60138783 | CS |
12 | -4.31 | -35.4440789474 | 12.16 | 12.85 | 7.85 | 357551 | 9.72015752 | CS |
26 | -4.47 | -36.2824675325 | 12.32 | 15.5 | 7.85 | 360175 | 11.16414448 | CS |
52 | -4.76 | -37.7478191911 | 12.61 | 16.88 | 7.85 | 465843 | 12.34679722 | CS |
156 | -4.92 | -38.5277995301 | 12.77 | 17.345 | 4.12 | 346949 | 10.65499245 | CS |
260 | -8.01 | -50.5044136192 | 15.86 | 45 | 4.12 | 316678 | 15.67732677 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約